WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation

Autor: Aleksandra Sejda, Wiesława Grajkowska, Joanna Trubicka, Ewa Szutowicz, Tomasz Wojdacz, Wojciech Kloc, Ewa Iżycka-Świeszewska

Publikováno v: Folia Neuropathologica, Vol 60, Iss 2, Pp 137-152 (2022)

The 5th edition of World Health Organization (WHO) Central Nervous System (CNS) tumours classification has transformed the pathological diagnosis of gliomas from purely histological to the multilayered integrated one with molecular biomarkers necessa

Externí odkaz: https://doaj.org/article/0b6cf9b691b248ed847e0939fd8f25d8

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

Autor: Magdalena Ratajska, Wojciech Biernat, Krzysztof Konopa, Aleksandra Szczesna, Jacek Jassem, Ewa Szutowicz-Zielińska, Małgorzata Suszko-Każarnowicz, Renata Duchnowska, Rafal Dziadziuszko, Aleksander Sowa, Anna Kowalczyk, Janusz Limon, Tomasz Burzykowski

Publikováno v: Oncotarget

// Ewa Szutowicz-Zielinska 1,* , Krzysztof Konopa 1,* , Anna Kowalczyk 1 , Malgorzata Suszko-Kazarnowicz 2 , Renata Duchnowska 3 , Aleksandra Szczesna 4 , Magdalena Ratajska 5 , Aleksander Sowa 6 , Janusz Limon 5 , Wojciech Biernat 7 , Tomasz Burzyko

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b5960c16a2af7bba228a6e1bd25d1d8
http://europepmc.org/articles/PMC5370039

Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study

Autor: Dawid Sigorski, Ewa Bien, Wojciech Kloc, Elżbieta Adamkiewicz-Drożyńska, Wojciech Rogowski, Edyta Szurowska, Ewa Szutowicz-Zielińska, Joanna Stefanowicz, Ewa Izycka-Swieszewska, Magdalena Koczkowska

Publikováno v: BioMed Research International
BioMed Research International, Vol 2018 (2018)

This study presents a unique series of malignant supratentorial gliomas in children previously cured from non-CNS primary cancer. On neuroimaging these tumors were not specific, so the patients were suspected of cerebral recurrence of their primary n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64258f1ce1acbb9e2f1933ad72644bcc
http://europepmc.org/articles/PMC5899852

Journal Club

Autor: Anna Kowalczyk, Ewa Szutowicz-Zielińska, Anna Wrona, Krzysztof Konopa

Publikováno v: Nowotwory. Journal of Oncology. 64:367-372

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b49ec9f3c4ba9ed8a615394822436a
https://doi.org/10.5603/njo.2014.0063

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Autor: Astra M. Liepa, Patrick Peterson, Martin Reck, Mark A. Socinski, Egbert F. Smit, Nick Thatcher, Susan C. Guba, Paul Lorigan, Ewa Szutowicz-Zielińska, Katherine B. Winfree

Publikováno v: Reck, M, Thatcher, N, Smit, E F, Lorigan, P, Szutowicz-Zielinska, E, Liepa, A M, Winfree, K B, Peterson, P, Guba, S C & Socinski, MA 2012, ' Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin ', Lung Cancer, vol. 78, no. 3, pp. 276-281 . https://doi.org/10.1016/j.lungcan.2012.09.002
Lung Cancer, 78(3), 276-281. Elsevier Ireland Ltd

Small cell lung cancer (SCLC) is associated with poor prognosis due to its early metastatic potential and lack of improved outcomes with newer cytotoxic agents. Identifying factors associated with clinical outcomes can help clinicians determine which

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9505cafea27a93757644da01b0f4aea0
https://doi.org/10.1016/j.lungcan.2012.09.002